1.Protective effect of Panaxadiol Saponins on acute alcohol myocardial inj ury in rabbits and mechanism
Xiaoqin WANG ; Yanwei DU ; Naiyan WEN ; Hongshuo CHU ; Na LI ; Bitao ZHU ; Yuming LU ; Lijing ZHAO
Journal of Jilin University(Medicine Edition) 2014;(3):471-475
Objective To observe the protective effect of Panaxadiol Saponins (PDS)on rabbit heart failure model induced by acute alcohol infusion, and to explore its action mechanism of protecting myocardium. Methods 1 5 healthy rabbits were randomly divided into control group, model group and PDS group, 5 rabbits in each group.The rabbits in control group were given 0.2 g·mL-1 saline by intravenous drip at constant speed,the rabbits in model group were given 20% ethanol with same method, and the rabbits in PDS group were given 0.025 g·kg-1 PDS by intravenous injection before intravenous drip of 20% ethanol.The hemodynamic changes were observed by ventricular intubation;the levels of serum lactate dehydrogenase (LDH),creatine kinase (CK), and creatine kinase isoenzyme (CKMB)were determined by colormetric method.The level of malondialdehyde (MDA)in myocardial tissue homogenate,the activities of superoxide dismutase (T-SOD),glutathione peroxidase (GSH-Px)and catalase (CAT)were also detected.Results Compared with control group,the left ventricular end-diastolic pressure (LVEDP)of the rabbits in model group was significantly decreased at 30 min(P<0.05);the serum LDH,CK and CKMB levels were increased(P<0.05),the MDA level in myocardial tissue homogenate was increased(P<0.05),and the T-SOD,GSH-Px and CAT activities were decreased (P<0.05).Compared with model group,the LVEDP of the rabbits in PDS group was increased,the serum LDH,CK,and CKMB levels were decreased(P<0.05),the MDA level was decreased(P<0.05),and the activities of T-SOD,GSH-Px and CAT were increased(P<0.05).Conclusion PDS has protective effect on heart failure induced by acute alcohol infusion,and its mechanism may be related to the improvement of cardiac peroxidation.
2.Patent analysis on Cariprazine: A novel antipsychotic agent
Chinese Journal of Medical Science Research Management 2019;32(3):193-198
Objective Cariprazine is the first orally active dopamine D3-preferring D3/D2 receptor partial agonist as antipsychotic agents.It receives a lot of concern for its remarkable efficacy and broad market prospect.In this article,overall application status of cariprazine patent,which includes the patent application quantity,applicants and technical topics,as well as possible technical obstacles were statistically analyzed.Methods The patent quantitative analysis method was used,combing with pharmacy expertise,to analyze the patent application situation at home and abroad.Results The patent technology of cariprazine involves product,process,new use,component of combination,formulation and general interest.Conclusions The concern of patent situation for cariprazine was high.Patents about different salt and its crystal,analytical method and impurities should be dug up by domestic generic pharmaceutical enterprises for further generic drug development considering the existing technology barrier.